Medivie Therapeutic Ltd (MDVI) - Cash Flow Conversion Efficiency

Latest as of June 2021: 0.217x

Based on the latest financial reports, Medivie Therapeutic Ltd (MDVI) has a cash flow conversion efficiency ratio of 0.217x as of June 2021. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-966.00K ≈ $-2.59K USD) by net assets (ILA-4.46 Million ≈ $-11.95K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Medivie Therapeutic Ltd balance sheet independence to measure how much of total assets are equity-financed.

Medivie Therapeutic Ltd - Cash Flow Conversion Efficiency Trend (2010–2020)

This chart illustrates how Medivie Therapeutic Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check MDVI cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Medivie Therapeutic Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medivie Therapeutic Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sleep Number Corp NASDAQ:SNBR	0.012x
MOVEBYBIKE EUROPE AB F:6ZR	-7.892x
SDCL EDGE Acquisition Corporation NYSE:SEDA	-0.009x
Helium One Global Ltd LSE:HE1	-0.001x
Vicarious Surgical Inc. NYSE:RBOT	-0.740x
Purple Biotech Ltd TA:KTOV	-0.041x
Mongolia Growth Group Ltd. V:YAK-H	-0.015x
SECITS Holding AB (publ) ST:SECI	0.666x

Annual Cash Flow Conversion Efficiency for Medivie Therapeutic Ltd (2010–2020)

The table below shows the annual cash flow conversion efficiency of Medivie Therapeutic Ltd from 2010 to 2020. For the full company profile with market capitalisation and key ratios, see Medivie Therapeutic Ltd (MDVI) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2020-12-31	ILA3.73 Million ≈ $10.00K	ILA-3.88 Million ≈ $-10.41K	-1.041x	-81.64%
2019-12-31	ILA5.88 Million ≈ $15.76K	ILA-3.37 Million ≈ $-9.03K	-0.573x	-38.84%
2018-12-31	ILA12.18 Million ≈ $32.65K	ILA-5.03 Million ≈ $-13.48K	-0.413x	-127.05%
2017-12-31	ILA16.26 Million ≈ $43.60K	ILA-2.96 Million ≈ $-7.93K	-0.182x	+97.06%
2016-12-31	ILA577.00K ≈ $1.55K	ILA-3.57 Million ≈ $-9.58K	-6.194x	-192.21%
2015-12-31	ILA-527.00K ≈ $-1.41K	ILA-3.54 Million ≈ $-9.49K	6.717x	+605.14%
2014-12-31	ILA2.26 Million ≈ $6.05K	ILA-3.00 Million ≈ $-8.04K	-1.330x	-172.72%
2013-12-31	ILA-1.52 Million ≈ $-4.08K	ILA-2.79 Million ≈ $-7.47K	1.829x	+117.83%
2012-12-31	ILA1.22 Million ≈ $3.27K	ILA-12.52 Million ≈ $-33.57K	-10.254x	-172.59%
2011-12-31	ILA3.65 Million ≈ $9.80K	ILA-13.74 Million ≈ $-36.85K	-3.762x	-321.61%
2010-12-31	ILA-5.68 Million ≈ $-15.24K	ILA-9.65 Million ≈ $-25.87K	1.697x	--

About Medivie Therapeutic Ltd

TA:MDVI Israel Machinery, Tools, Heavy Vehicles, Trains & Ships

Market Cap

$462.01K

ILA172.33 Million ILA

Market Cap Rank

#30950 Global

#459 in Israel

Share Price

ILA59.90

Change (1 day)

+5.27%

52-Week Range

ILA17.00 - ILA138.00

All Time High

ILA140000.00